NDARC’s health economics and biostatistics program conducts policy relevant research to assist and improve decision making and resource allocation in the alcohol and other drugs (AOD) sector. 

This includes:

  • The societal costs and benefits/effects of new treatments, interventions, and policy changes.
  • Measuring and valuing treatments and policies.
  • The impact of new treatments and policies on costs, health outcomes and quality of life.